Medically reviewed by Andrew Greenberg, MD Arcus senilis is a term for the discoloration of the cornea, the transparent part ...

The company’s pipeline of products based on allogeneic chimeric antigen receptor (CAR)-T cells are engineered ex vivo using the ARCUS platform to optimize donor cells and thereby improve ...

Paris Saint-Germain (1st) take on Angers (14th) Parc des Princes as part of the 28th day of Ligue 1 2024-2025. In a press ...

Azervabtagene zapreleucel ((azer-cel)) is an allogeneic CAR-T, originally developed by Precision Biosciences, utilising their ARCUS gene editing platform. Azer-cel are off-the-shelf CAR-Ts ...

Barclays analyst Peter Lawson maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) today and set a price target of $29.00. The ...

Abyss is headquartered in Kristiansund, Norway The acquisition is the eighth by Arcus European Infrastructure Fund 3 SCSp The transaction is expected to complete later this month. Arcus ...

Terry Rosen, CEO, Arcus Biosciences: No, not at all. Zero. So maybe they’re letting people go in other areas or withholding funding in other areas. But we haven’t seen we’re having a lot of ...

Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been predicting.

And then FDA interactions, have there been any changes? Terry Rosen, CEO, Arcus Biosciences: No, not at all. Zero. So maybe they’re letting people go in other areas or withholding funding in other ...